ID   RM-1 [Mouse prostate carcinoma]
AC   CVCL_B459
SY   RM1
DR   BTO; BTO_0003780
DR   ATCC; CRL-3310
DR   CCRID; 3101MOUTCM14
DR   CLS; 305168
DR   Ubigene; YC-C049
DR   Wikidata; Q54950629
RX   PubMed=7538321;
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-C049
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17,18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 16
ST   Mouse STR X-1: 27
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=7538321; DOI=10.1016/0960-0760(95)00001-G;
RA   Baley P.A., Yoshida K., Qian W., Sehgal I., Thompson T.C.;
RT   "Progression to androgen insensitivity in a novel in vitro mouse model
RT   for prostate cancer.";
RL   J. Steroid Biochem. Mol. Biol. 52:403-413(1995).
//